Accurate imaging is important for patients diagnosed with locally advanced breast cancer for monitoring tumor size and guiding treatment decisions. Currently utilized standard imaging and clinical breast examinations are not always accurate. The purpose of this exhibit is to highlight non-contrast cone-beam breast computed tomography (CBBCT) as a promising modality for evaluating tumor response during and following neoadjuvant treatment of breast cancer.
1) Briefly describe the current clinical and standard imaging modalities that are used to assess tumor response in patients undergoing neoadjuvant treatment of breast cancer.
2) Review CBBCT and compare it with other imaging modalities such as mammography, ultrasound, and magnetic resonance imaging.
3) Illustrate the advantages of using CBBCT to assess changes in tumor response prior to, during and following neoadjuvant treatment of breast cancer through a variety of image rich cases.
CBBCT imaging before, during and after neoadjuvant treatment of breast cancer can provide more accurate imaging than clinical evaluation, better imaging for follow up and for tumor localization and potentially improve surgical and radiation therapy outcomes.
Fang, A,
Chan, S,
O'Connell, A,
Cone-beam Breast Computed Tomography: A Promising Modality for Assessing Tumor Response Following Neoadjuvant Treatment of Breast Cancer. Radiological Society of North America 2013 Scientific Assembly and Annual Meeting, December 1 - December 6, 2013 ,Chicago IL.
http://archive.rsna.org/2013/13015076.html
